• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有肝肺转移及原发性甲状旁腺功能亢进的恶性胰岛素瘤:病例报告及文献复习

Malignant insulinoma with hepatic and pulmonary metastases associated with primary hyperparathyroidism. Case report and review of the literature.

作者信息

Albu A, Zirnea A, Georgescu O, Terzea D, Jinga D, Fica S

机构信息

Emergency University Elias Hospital, Endocrinology Department, Marasti nr. 17, Sect 1, Bucharest, Romania.

出版信息

J Med Life. 2008 Apr-Jun;1(2):210-7.

PMID:20108468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5654079/
Abstract

Malignant insulinomas are rare tumors (10% of insulinomas) that often present as mnulticentric macro nodules with multiple liver metastases before diagnosis. We report the case of a 55 year old female with a medical history of severe hypoglycemic attacks for two months. Blood tests showed a decreased value of glycemia (30 mg/dl) associated with increased insulin level (l6 microU/ml) and an increased glycemia/insulinemia ratio of 1.87 supporting the diagnosis of insulinoma. Abdominal CT showed a 1.5 cm mass localized in the head of the pancreas with disseminated hepatic tumors, confirmed as neuroendocrine metastases by biopsy (which proved the presence of a malignant insulinoma). Primary hyperparathyroidism was diagnosed based on mild elevation of calcium (10.4 mg/dl) associated with a high level of PTH (71.2 pg/ml). The coexistence of the two endocrinopathies suggested the presence of type 1 multiple endocrine neoplasia (MEN 1). Because of multiple hepatic masses and liver function impairment, surgery and hepatic artery embolization were not performed. Somatostatin analog therapy was started with symptomatic control in the beginning, but rapid loss of beneficial effect. Finally, systemic chemotherapy with doxorubicin was administered, but the disease was progressive and after three months we decided to stop it. The patient died at home after one month, probably in hypoglycemic coma.

摘要

恶性胰岛素瘤是罕见肿瘤(占胰岛素瘤的10%),常在诊断前表现为多中心大结节并伴有多处肝转移。我们报告一例55岁女性病例,其有两个月严重低血糖发作的病史。血液检查显示血糖值降低(30mg/dl),同时胰岛素水平升高(16微单位/毫升),血糖/胰岛素血症比值为1.87升高,支持胰岛素瘤的诊断。腹部CT显示胰腺头部有一个1.5厘米的肿块,伴有散在的肝脏肿瘤,活检证实为神经内分泌转移瘤(证实存在恶性胰岛素瘤)。原发性甲状旁腺功能亢进根据钙轻度升高(10.4mg/dl)伴甲状旁腺激素水平升高(71.2pg/ml)而诊断。两种内分泌疾病并存提示存在1型多发性内分泌肿瘤(MEN 1)。由于存在多处肝脏肿块和肝功能损害,未进行手术及肝动脉栓塞。开始使用生长抑素类似物治疗,起初有症状控制,但很快失去有益效果。最后给予阿霉素全身化疗,但疾病仍进展,三个月后我们决定停止化疗。患者在一个月后在家中死亡,可能死于低血糖昏迷。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/4cb1d9e2e76f/JMedLife-1-210-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/0b3f91fc29d8/JMedLife-1-210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/091aab176a74/JMedLife-1-210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/01c23b47a943/JMedLife-1-210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/9da4c6fefdd8/JMedLife-1-210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/12c08c22d0ff/JMedLife-1-210-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/9bc5ac9d428a/JMedLife-1-210-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/4cb1d9e2e76f/JMedLife-1-210-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/0b3f91fc29d8/JMedLife-1-210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/091aab176a74/JMedLife-1-210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/01c23b47a943/JMedLife-1-210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/9da4c6fefdd8/JMedLife-1-210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/12c08c22d0ff/JMedLife-1-210-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/9bc5ac9d428a/JMedLife-1-210-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4951/5654079/4cb1d9e2e76f/JMedLife-1-210-g007.jpg

相似文献

1
Malignant insulinoma with hepatic and pulmonary metastases associated with primary hyperparathyroidism. Case report and review of the literature.伴有肝肺转移及原发性甲状旁腺功能亢进的恶性胰岛素瘤:病例报告及文献复习
J Med Life. 2008 Apr-Jun;1(2):210-7.
2
Malignant insulinoma presenting as metastatic liver tumor. Case report and review of the literature.表现为转移性肝肿瘤的恶性胰岛素瘤。病例报告及文献复习
J Exp Clin Cancer Res. 2007 Dec;26(4):603-7.
3
Prompt resolution of hypoglycemia by hepatic transarterial embolization for malignant insulinoma with multiple liver metastases.经肝动脉栓塞术迅速解决伴有多发肝转移的恶性胰岛素瘤所致低血糖症
Acta Med Okayama. 2014;68(5):303-6. doi: 10.18926/AMO/52900.
4
Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.一名40岁患有对2型生长抑素受体呈阳性的恶性胰岛素瘤的女性,在接受生长抑素类似物治疗后实现了完全临床缓解且肝转移灶消失。
Horm Res. 2006;65(3):120-5. doi: 10.1159/000091408. Epub 2006 Feb 9.
5
Insulinoma with focal hepatic lesions: malignant insulinoma?胰岛素瘤伴肝脏局灶性病变:恶性胰岛素瘤?
BMJ Case Rep. 2015 Dec 15;2015:bcr2015212811. doi: 10.1136/bcr-2015-212811.
6
Malignant insulinoma: permanent hepatic artery embolization of liver metastases--preliminary results.恶性胰岛素瘤:肝转移灶的永久性肝动脉栓塞——初步结果
Cardiovasc Intervent Radiol. 1995 Nov-Dec;18(6):353-9. doi: 10.1007/BF00338301.
7
[Malignant insulinoma].[恶性胰岛素瘤]
Orv Hetil. 2011 Mar 6;152(10):398-402. doi: 10.1556/OH.2011.29058.
8
Pasireotide for malignant insulinoma.帕西瑞肽用于治疗恶性胰岛素瘤。
Hormones (Athens). 2016 Apr;15(2):271-276. doi: 10.14310/horm.2002.1639.
9
Rapidly progressing malignant insulinoma presented with multiple liver metastases: a case report.快速进展的恶性胰岛素瘤伴多发肝转移:一例报告
J Gastrointest Cancer. 2010 Dec;41(4):272-4. doi: 10.1007/s12029-010-9157-9.
10
Focal hepatic steatosis surrounding a metastatic insulinoma.转移性胰岛素瘤周围的局灶性肝脂肪变性。
Pathol Int. 2008 Jan;58(1):59-63. doi: 10.1111/j.1440-1827.2007.02190.x.

引用本文的文献

1
Malignant Insulinoma with Multiple Liver Metastases and Hypercalcitoninemia in a Patient with Type 2 Diabetes Mellitus Presenting as Recurrent Episodes of Diaphoresis due to Severe Hypoglycemia.一名2型糖尿病患者出现恶性胰岛素瘤伴多发肝转移及高降钙素血症,表现为因严重低血糖导致的反复出汗发作。
Case Rep Endocrinol. 2020 Jan 31;2020:4239679. doi: 10.1155/2020/4239679. eCollection 2020.
2
Peptide receptor radionuclide therapy with Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review.Lu-DOTA-TATE 肽受体放射性核素治疗恶性胰岛素瘤的疗效:一系列病例报告和文献复习。
J Endocrinol Invest. 2019 Mar;42(3):249-260. doi: 10.1007/s40618-018-0911-3. Epub 2018 Jun 9.

本文引用的文献

1
Serpin peptidase inhibitor clade A member 1 as a potential marker for malignancy in insulinomas.丝氨酸蛋白酶抑制剂A族成员1作为胰岛素瘤恶性潜能的标志物
Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5322-30. doi: 10.1158/1078-0432.CCR-06-1477. Epub 2007 Sep 12.
2
Chromosomal instability predicts metastatic disease in patients with insulinomas.染色体不稳定性可预测胰岛素瘤患者的转移性疾病。
Endocr Relat Cancer. 2005 Jun;12(2):435-47. doi: 10.1677/erc.1.00960.
3
Malignant insulinoma: spectrum of unusual clinical features.恶性胰岛素瘤:不寻常临床特征谱
Cancer. 2005 Jul 15;104(2):264-72. doi: 10.1002/cncr.21179.
4
Giant insulinoma: case report and review of the literature.巨大胰岛素瘤:病例报告及文献复习
J Clin Endocrinol Metab. 2005 Jan;90(1):575-80. doi: 10.1210/jc.2004-0825. Epub 2004 Nov 2.
5
The diagnosis and medical management of advanced neuroendocrine tumors.晚期神经内分泌肿瘤的诊断与药物治疗
Endocr Rev. 2004 Jun;25(3):458-511. doi: 10.1210/er.2003-0014.
6
Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experience.善龙(长效醋酸奥曲肽)治疗恶性类癌综合征:3年经验总结
Aliment Pharmacol Ther. 2003 Feb;17(3):437-44. doi: 10.1046/j.1365-2036.2003.01420.x.
7
Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.手术对伴有淋巴结和肝转移的中肠类癌疾病预后的影响。
World J Surg. 2002 Aug;26(8):991-7. doi: 10.1007/s00268-002-6630-z. Epub 2002 May 21.
8
Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid.一名恶性类癌患者对长效生长抑素类似物兰瑞肽和奥曲肽的不同反应
Oncology. 2001;60(2):141-5. doi: 10.1159/000055311.
9
Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide.用兰瑞肽预处理的转移性神经内分泌肿瘤患者使用长效醋酸奥曲肽
Ann Oncol. 2000 Sep;11(9):1127-30. doi: 10.1023/a:1008383132024.
10
Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review.生长抑素类似物治疗神经内分泌GEP肿瘤:综述
Digestion. 2000;62 Suppl 1:84-91. doi: 10.1159/000051861.